Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial - Concepedia

Concepedia

Publication | Closed Access

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial

271

Citations

17

References

2005

Year

Jens Overgaard, Jesper Grau Eriksen, Marianne Nordsmark, Jan Alsner, Michael R. Horsman

The Lancet Oncology

Radiation TherapyDahanca 5MedicinePharmacologyHead And Neck CancerPlasma OsteopontinHypoxia Sensitiser NimorazoleNeck OncologyOncologyRadiation OncologyCancer Research

References

	Year	Citations

Page 1